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1. Introduction {#ehf212583-sec-0005}
===============

Scopus currently lists 38 060 different journals, with 320 journals publishing in the field of 'Cardiology and Cardiovascular Medicine'.[1](#ehf212583-bib-0001){ref-type="ref"} Many different scores worldwide try to rank journals with the help of different algorithms. The most important and renown score in Europe and the USA is the Thomson Scientific impact factor. Each summer, it is published for the previous year. For understanding the Thomson Scientific impact factor, one first has to comprehend how it is calculated. For example, the 2018 impact factor for any given journal was calculated by adding up all citations in 2018 referencing articles published in that journal in 2016 and 2017 and then dividing by the number of original articles and reviews published in 2016 and 2017 in that journal. For counting the number of citations, Thomson Scientific uses the Web of Science (WoS) database.[2](#ehf212583-bib-0002){ref-type="ref"} But there are also other sources for citation information available (e.g. Scopus[1](#ehf212583-bib-0001){ref-type="ref"} and Google Scholar[3](#ehf212583-bib-0003){ref-type="ref"}). Because we noticed that the number of citations for articles is often different in WoS, Scopus, and Google Scholar, we followed a structured approach to compare the number of citations and find possible differences.

2. Methods {#ehf212583-sec-0006}
==========

We included four journals in our analyses that focus on different cardiovascular and non‐cardiovascular research topics and have differing impact factors. We included two open access journals: the 'ESC Heart Failure' (ESC‐HF) and the 'Journal of cachexia, sarcopenia and muscle' (JCSM) and two standard subscription journals: the 'European Journal of Heart Failure' (EJHF) and the 'European Journal of Preventive Cardiology' (EJPC). Each of the journals has a different focus: ESC‐HF publishes basic, clinical, and translational research concerning heart failure; EJHF focuses on pathophysiologic research, diagnosis, prevention, and treatment development for cardiovascular diseases, with a main interest in heart failure; EJPC has the aim to share the latest knowledge on preventive and rehabilitative strategies of cardiovascular diseases; and JCSM is focused on better understanding the molecular background of wasting disorders with the purpose to improve the recognition and management of these diseases.

In order to get up‐to‐date numbers for our comparison, we considered the top 50 cited papers of the four journals according to WoS that were published between 1 January 2016 and 10 October 2019 (*Tables* [1](#ehf212583-tbl-0001){ref-type="table"}, [2](#ehf212583-tbl-0002){ref-type="table"}, [3](#ehf212583-tbl-0003){ref-type="table"}, [4](#ehf212583-tbl-0004){ref-type="table"}). For each of the 50 papers, we recorded the number of citations according to WoS, Scopus, and Google Scholar on 10 October 2019.

###### 

Top 50 of best cited articles published between 2016 until today in Eur J Prev Cardiol

  Nr.   First author            Title                                                                                                                                                                                                                                                                                                     Document type   Times cited in Web of Science   Times cited in Scopus   Times cited in Google Scholar   Reference
  ----- ----------------------- --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- --------------- ------------------------------- ----------------------- ------------------------------- -------------------------------------------
  1     Kotseva K               EUROASPIRE IV: A European Society of Cardiology survey on the lifestyle, risk factor and therapeutic management of coronary patients from 24 European countries                                                                                                                                           Article         353                             427                     651                             [4](#ehf212583-bib-0004){ref-type="ref"}
  2     Eckel N                 Metabolically healthy obesity and cardiovascular events: a systematic review and meta‐analysis                                                                                                                                                                                                            Review          76                              76                      96                              [5](#ehf212583-bib-0005){ref-type="ref"}
  3     Friis‐Møller N          An updated prediction model of the global risk of cardiovascular disease in HIV‐positive persons: the data‐collection on adverse effects of anti‐HIV drugs (D:A:D) study                                                                                                                                  Article         69                              70                      100                             [6](#ehf212583-bib-0006){ref-type="ref"}
  4     Kotseva K               Lifestyle and risk factor management in people at high risk of cardiovascular disease. A report from the European Society of Cardiology European Action on Secondary and Primary Prevention by Intervention to Reduce Events (EUROASPIRE) IV cross‐sectional survey in 14 European regions                Article         66                              78                      98                              [13](#ehf212583-bib-0013){ref-type="ref"}
  5     Rauch B                 The prognostic effect of cardiac rehabilitation in the era of acute revascularisation and statin therapy: a systematic review and meta‐analysis of randomized and non‐randomized studies ‐ The Cardiac Rehabilitation Outcome Study (CROS)                                                                Review          66                              77                      101                             [14](#ehf212583-bib-0014){ref-type="ref"}
  6     Price KJ                A review of guidelines for cardiac rehabilitation exercise programmes: is there an international consensus?                                                                                                                                                                                               Review          61                              67                      108                             [15](#ehf212583-bib-0015){ref-type="ref"}
  7     Mont L                  <https://www.ncbi.nlm.nih.gov/pubmed/27815537>                                                                                                                                                                                                                                                            Article         51                              60                      122                             [16](#ehf212583-bib-0016){ref-type="ref"}
  8     Vigorito C              <https://www.ncbi.nlm.nih.gov/pubmed/27940954>                                                                                                                                                                                                                                                            Article         47                              51                      60                              [17](#ehf212583-bib-0017){ref-type="ref"}
  9     Bonaccio MF             Adherence to the traditional Mediterranean diet and mortality in subjects with diabetes. Prospective results from the MOLI‐SANI study                                                                                                                                                                     Article         45                              51                      65                              [18](#ehf212583-bib-0018){ref-type="ref"}
  10    Roeters van Lennep EJ   Cardiovascular disease risk in women with premature ovarian insufficiency: a systematic review and meta‐analysis                                                                                                                                                                                          Article         45                              46                      78                              [19](#ehf212583-bib-0019){ref-type="ref"}
  11    Cooney MT               Cardiovascular risk estimation in older persons: SCORE O.P.                                                                                                                                                                                                                                               Article         41                              47                      53                              [20](#ehf212583-bib-0020){ref-type="ref"}
  12    Hansen D                The European Association of Preventive Cardiology Exercise Prescription in Everyday Practice and Rehabilitative Training (EXPERT) tool: a digital training and decision support system for optimized exercise prescription in cardiovascular disease. Concept, definitions and construction methodology   Article         40                              44                      51                              [21](#ehf212583-bib-0021){ref-type="ref"}
  13    Chu P                   <https://www.ncbi.nlm.nih.gov/pubmed/25510863>                                                                                                                                                                                                                                                            Review          38                              45                      103                             [22](#ehf212583-bib-0022){ref-type="ref"}
  14    Piepoli MF              <https://www.ncbi.nlm.nih.gov/pubmed/27600690>                                                                                                                                                                                                                                                            Review          37                              40                      84                              [23](#ehf212583-bib-0023){ref-type="ref"}
  15    Alharbi M               <https://www.ncbi.nlm.nih.gov/pubmed/26907794>                                                                                                                                                                                                                                                            Article         35                              40                      67                              [24](#ehf212583-bib-0024){ref-type="ref"}
  16    D\'Ascenzi F            <https://www.ncbi.nlm.nih.gov/pubmed/25990017>                                                                                                                                                                                                                                                            Review          35                              37                      44                              [25](#ehf212583-bib-0025){ref-type="ref"}
  17    Fukuta H                <https://www.ncbi.nlm.nih.gov/pubmed/25520380>                                                                                                                                                                                                                                                            Article         35                              35                      60                              [26](#ehf212583-bib-0026){ref-type="ref"}
  18    Hobbs FDR               <https://www.ncbi.nlm.nih.gov/pubmed/25701017>                                                                                                                                                                                                                                                            Article         34                              37                      47                              [27](#ehf212583-bib-0027){ref-type="ref"}
  19    Frederix I              <https://www.ncbi.nlm.nih.gov/pubmed/26289723>                                                                                                                                                                                                                                                            Article         33                              39                      47                              [28](#ehf212583-bib-0028){ref-type="ref"}
  20    Solberg EE              <https://www.ncbi.nlm.nih.gov/pubmed/26285770>                                                                                                                                                                                                                                                            Article         33                              34                      57                              [29](#ehf212583-bib-0029){ref-type="ref"}
  21    Groenewegen KA          Vascular age to determine cardiovascular disease risk: a systematic review of its concepts, definitions, and clinical applications                                                                                                                                                                        Review          32                              35                      58                              [30](#ehf212583-bib-0030){ref-type="ref"}
  22    Sato T                  Cardiopulmonary exercise testing as prognostic indicators: comparisons among heart failure patients with reduced, mid‐range and preserved ejection fraction                                                                                                                                               Article         31                              37                      32                              [31](#ehf212583-bib-0031){ref-type="ref"}
  23    Pedersen SS             <https://www.ncbi.nlm.nih.gov/pubmed/28618908>                                                                                                                                                                                                                                                            Article         31                              29                      35                              [32](#ehf212583-bib-0032){ref-type="ref"}
  24    Pallisgaard JL          <https://www.ncbi.nlm.nih.gov/pubmed/26254188>                                                                                                                                                                                                                                                            Article         31                              26                      39                              [33](#ehf212583-bib-0033){ref-type="ref"}
  25    Uddin J                 Predictors of exercise capacity following exercise‐based rehabilitation in patients with coronary heart disease and heart failure: a meta‐regression analysis                                                                                                                                             Article         30                              35                      44                              [34](#ehf212583-bib-0034){ref-type="ref"}
  26    Bohm P                  Data from a nationwide registry on sports‐related sudden cardiac deaths in Germany                                                                                                                                                                                                                        Article         30                              36                      63                              [35](#ehf212583-bib-0035){ref-type="ref"}
  27    Hall AJ                 Association between osteoarthritis and cardiovascular disease: systematic review and meta‐analysis                                                                                                                                                                                                        Review          29                              34                      47                              [36](#ehf212583-bib-0036){ref-type="ref"}
  28    Frederix I              Cardiac telerehabilitation: a novel cost‐efficient care delivery strategy that can induce long‐term health benefits                                                                                                                                                                                       Article         29                              34                      34                              [37](#ehf212583-bib-0037){ref-type="ref"}
  29    Heida KY                Cardiovascular risk management after reproductive and pregnancy‐related disorders: a Dutch multidisciplinary evidence‐based guideline                                                                                                                                                                     Review          29                              33                      53                              [38](#ehf212583-bib-0038){ref-type="ref"}
  30    Huang G                 Dose‐response relationship of cardiorespiratory fitness adaptation to controlled endurance training in sedentary older adults                                                                                                                                                                             Review          29                              28                      49                              [39](#ehf212583-bib-0039){ref-type="ref"}
  31    Kraal JJ                <https://www.ncbi.nlm.nih.gov/pubmed/28534417>                                                                                                                                                                                                                                                            Article         28                              33                      36                              [40](#ehf212583-bib-0040){ref-type="ref"}
  32    Taggar JS               <https://www.ncbi.nlm.nih.gov/pubmed/26464292>                                                                                                                                                                                                                                                            Review          28                              33                      48                              [41](#ehf212583-bib-0041){ref-type="ref"}
  33    Pfaeffli Dale L         The effectiveness of mobile‐health behaviour change interventions for cardiovascular disease self‐management: A systematic review                                                                                                                                                                         Review          27                              29                      67                              [42](#ehf212583-bib-0042){ref-type="ref"}
  34    Sandri M                Chronic heart failure and aging--effects of exercise training on endothelial function and mechanisms of endothelial regeneration: results from the Leipzig Exercise Intervention in Chronic heart failure and Aging (LEICA) study                                                                         Article         27                              34                      50                              [43](#ehf212583-bib-0043){ref-type="ref"}
  35    Kotseva K               Determinants of participation and risk factor control according to attendance in cardiac rehabilitation programmes in coronary patients in Europe: EUROASPIRE IV survey                                                                                                                                   Article         27                              31                      28                              [44](#ehf212583-bib-0044){ref-type="ref"}
  36    Gorenek Chair B         <https://www.ncbi.nlm.nih.gov/pubmed/27815538>)                                                                                                                                                                                                                                                           Article         27                              30                      71                              [45](#ehf212583-bib-0045){ref-type="ref"}
  37    Coppetti T              <https://www.ncbi.nlm.nih.gov/pubmed/28464700>                                                                                                                                                                                                                                                            Article         26                              32                      35                              [46](#ehf212583-bib-0046){ref-type="ref"}
  38    Joshi PH                Association of high‐density lipoprotein subclasses and incident coronary heart disease: the Jackson Heart and Framingham Offspring Cohort Studies                                                                                                                                                         Article         26                              27                      41                              [47](#ehf212583-bib-0047){ref-type="ref"}
  39    Pogosova N              Psychosocial risk factors in relation to other cardiovascular risk factors in coronary heart disease: results from the EUROASPIRE IV survey. A registry from the European Society of Cardiology                                                                                                           Article         26                              26                      34                              [48](#ehf212583-bib-0048){ref-type="ref"}
  40    Ruddox V                <https://www.ncbi.nlm.nih.gov/pubmed/28617620>                                                                                                                                                                                                                                                            Review          25                              27                      34                              [49](#ehf212583-bib-0049){ref-type="ref"}
  41    Tschentscher M          High‐intensity interval training is not superior to other forms of endurance training during cardiac rehabilitation                                                                                                                                                                                       Article         25                              25                      45                              [50](#ehf212583-bib-0050){ref-type="ref"}
  42    Ekblom‐Bak E            Isotemporal substitution of sedentary time by physical activity of different intensities and bout lengths, and its associations with metabolic risk                                                                                                                                                       Article         24                              28                      35                              [51](#ehf212583-bib-0051){ref-type="ref"}
  43    Maiorino Mi             <https://www.ncbi.nlm.nih.gov/pubmed/27798369>                                                                                                                                                                                                                                                            Article         24                              25                      29                              [52](#ehf212583-bib-0052){ref-type="ref"}
  44    Willeit P               Inflammatory markers and extent and progression of early atherosclerosis: meta‐analysis of individual‐participant‐data from 20 prospective studies of the PROG‐IMT collaboration                                                                                                                          Article         23                              29                      52                              [53](#ehf212583-bib-0053){ref-type="ref"}
  45    Stefler D               <https://www.ncbi.nlm.nih.gov/pubmed/25903971>                                                                                                                                                                                                                                                            Article         23                              28                      34                              [54](#ehf212583-bib-0054){ref-type="ref"}
  46    Ribeiro G               Cardiac rehabilitation programme after transcatheter aortic valve implantation versus surgical aortic valve replacement: systematic review and meta‐analysis                                                                                                                                              Review          23                              27                      28                              [55](#ehf212583-bib-0055){ref-type="ref"}
  47    Kozela M                The association of depressive symptoms with cardiovascular and all‐cause mortality in Central and Eastern Europe: prospective results of the HAPIEE study                                                                                                                                                 Article         23                              26                      33                              [56](#ehf212583-bib-0056){ref-type="ref"}
  48    Auer J                  <https://www.ncbi.nlm.nih.gov/pubmed/25230981>?                                                                                                                                                                                                                                                           Article         23                              26                      40                              [57](#ehf212583-bib-0057){ref-type="ref"}
  49    Heida KY                Cardiovascular disease risk in women with a history of spontaneous preterm delivery: a systematic review and meta‐analysis                                                                                                                                                                                Review          23                              24                      36                              [58](#ehf212583-bib-0058){ref-type="ref"}
  50    Shi Y                   <https://www.ncbi.nlm.nih.gov/pubmed/28925280>?                                                                                                                                                                                                                                                           Letter          23                              22                      26                              [59](#ehf212583-bib-0059){ref-type="ref"}

###### 

Top 50 of best cited articles published between 2016 until today in J Cachexia Sarcopenia Muscle

  Nr.   First author          Title                                                                                                                                                                                                                                                 Document type        Times cited in Web of Science   Times cited in Scopus   Times cited in Google Scholar   Reference
  ----- --------------------- ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- -------------------- ------------------------------- ----------------------- ------------------------------- --------------------------------------------
  1     von Haehling S        Ethical guidelines for publishing in the journal of cachexia, sarcopenia and muscle: update 2017                                                                                                                                                      Editorial Material   113                             168                     178                             [60](#ehf212583-bib-0060){ref-type="ref"}
  2     Malmstrom T           SARC‐F: a symptom score to predict persons with sarcopenia at risk for poor functional outcomes                                                                                                                                                       Article              104                             111                     170                             [61](#ehf212583-bib-0061){ref-type="ref"}
  3     Montano‐Loza A        Sarcopenic obesity and myosteatosis are associated with higher mortality in patients with cirrhosis                                                                                                                                                   Article              80                              90                      125                             [62](#ehf212583-bib-0062){ref-type="ref"}
  4     Anker SD              Welcome to the ICD‐10 code for sarcopenia                                                                                                                                                                                                             Editorial Material   73                              88                      150                             [63](#ehf212583-bib-0063){ref-type="ref"}
  5     Brown JC              Sarcopenia and mortality among a population‐based sample of community‐dwelling older adult                                                                                                                                                            Article              66                              71                      100                             [64](#ehf212583-bib-0064){ref-type="ref"}
  6     Kalafateli M          <https://www.ncbi.nlm.nih.gov/pubmed/27239424>                                                                                                                                                                                                        Article              53                              61                      89                              [65](#ehf212583-bib-0065){ref-type="ref"}
  7     von Haehling S        Prevalence and clinical impact of cachexia in chronic illness in Europe, USA, and Japan: facts and numbers update 2016                                                                                                                                Editorial Material   52                              55                      87                              [66](#ehf212583-bib-0066){ref-type="ref"}
  8     Rutten IJ             <https://www.ncbi.nlm.nih.gov/pubmed/27030813>.                                                                                                                                                                                                       Article              52                              63                      71                              [67](#ehf212583-bib-0067){ref-type="ref"}
  9     Tyrovolas S           <https://www.ncbi.nlm.nih.gov/pubmed/27239412>                                                                                                                                                                                                        Article              51                              59                      80                              [68](#ehf212583-bib-0068){ref-type="ref"}
  10    Buckinx F             Pitfalls in the measurement of muscle mass: a need for a reference standard                                                                                                                                                                           Article              46                              54                      73                              [69](#ehf212583-bib-0069){ref-type="ref"}
  11    Solheim TS            <https://www.ncbi.nlm.nih.gov/pubmed/28614627>                                                                                                                                                                                                        Article              44                              50                      70                              [70](#ehf212583-bib-0070){ref-type="ref"}
  12    Stewart Coats AJ      Espindolol for the treatment and prevention of cachexia in patients with stage III/IV non‐small cell lung cancer or colorectal cancer: a randomized, double‐blind, placebo‐controlled, international multicentre phase II study (the ACT‐ONE trial)   Article              44                              60                      62                              [71](#ehf212583-bib-0071){ref-type="ref"}
  13    Loncar G              Cardiac cachexia: hic et nunc                                                                                                                                                                                                                         Review               42                              43                      56                              [72](#ehf212583-bib-0072){ref-type="ref"}
  14    van Dijk DP           Low skeletal muscle radiation attenuation and visceral adiposity are associated with overall survival and surgical site infections in patients with pancreatic cancer                                                                                 Article              41                              48                      58                              [73](#ehf212583-bib-0073){ref-type="ref"}
  15    Leong DP              Reference ranges of handgrip strength from 125,462 healthy adults in 21 countries: a prospective urban rural epidemiologic (PURE) study                                                                                                               Article              41                              49                      71                              [74](#ehf212583-bib-0074){ref-type="ref"}
  16    Sanders KJ            <https://www.ncbi.nlm.nih.gov/pubmed/27066314>                                                                                                                                                                                                        Review               39                              38                      60                              [75](#ehf212583-bib-0075){ref-type="ref"}
  17    Boengler K            Mitochondria and ageing: role in heart, skeletal muscle and adipose tissue                                                                                                                                                                            Review               36                              38                      57                              [76](#ehf212583-bib-0076){ref-type="ref"}
  18    Rutten IJG            Psoas muscle area is not representative of total skeletal muscle area in the assessment of sarcopenia in ovarian cancer                                                                                                                               Article              31                              41                      49                              [77](#ehf212583-bib-0077){ref-type="ref"}
  19    Snijders T            Muscle fibre capillarization is a critical factor in muscle fibre hypertrophy during resistance exercise training in older men                                                                                                                        Article              30                              37                      49                              [78](#ehf212583-bib-0078){ref-type="ref"}
  20    Holeček M             <https://www.ncbi.nlm.nih.gov/pubmed/28493406>                                                                                                                                                                                                        Review               30                              34                      62                              [79](#ehf212583-bib-0079){ref-type="ref"}
  21    Barbosa‐Silva T       Prevalence of sarcopenia among community‐dwelling elderly of a medium‐sized South American city: results of the COMO VAI? study                                                                                                                       Article              30                              38                      74                              [80](#ehf212583-bib-0080){ref-type="ref"}
  22    Foong YC              <https://www.ncbi.nlm.nih.gov/pubmed/27239404>                                                                                                                                                                                                        Article              30                              31                      41                              [81](#ehf212583-bib-0081){ref-type="ref"}
  23    Sente T               Adiponectin resistance in skeletal muscle: pathophysiological implications in chronic heart failure                                                                                                                                                   Review               30                              31                      46                              [82](#ehf212583-bib-0082){ref-type="ref"}
  24    van Vugt JL           <https://www.ncbi.nlm.nih.gov/pubmed/27897414>                                                                                                                                                                                                        Article              29                              36                      47                              [83](#ehf212583-bib-0083){ref-type="ref"}
  25    Mochamat              <https://www.ncbi.nlm.nih.gov/pubmed/27897391>                                                                                                                                                                                                        Review               29                              31                      42                              [84](#ehf212583-bib-0084){ref-type="ref"}
  26    Sakuma K              p62/SQSTM1 but not LC3 is accumulated in sarcopenic muscle of mice                                                                                                                                                                                    Article              29                              32                      42                              [85](#ehf212583-bib-0085){ref-type="ref"}
  27    Batista ML Jr         <https://www.ncbi.nlm.nih.gov/pubmed/27066317>                                                                                                                                                                                                        Article              29                              31                      43                              [86](#ehf212583-bib-0086){ref-type="ref"}
  28    Morley JE             Anorexia of ageing: a key component in the pathogenesis of both sarcopenia and cachexia                                                                                                                                                               Editorial Material   28                              26                      38                              [87](#ehf212583-bib-0087){ref-type="ref"}
  29    Nijholt W             The reliability and validity of ultrasound to quantify muscles in older adults: a systematic review                                                                                                                                                   Review               28                              36                      53                              [88](#ehf212583-bib-0088){ref-type="ref"}
  30    Brown JL              Mitochondrial degeneration precedes the development of muscle atrophy in progression of cancer cachexia in tumour‐bearing mice                                                                                                                        Article              27                              26                      41                              [89](#ehf212583-bib-0089){ref-type="ref"}
  31    Martone AM            The incidence of sarcopenia among hospitalized older patients: results from the Glisten study                                                                                                                                                         Article              26                              27                      37                              [90](#ehf212583-bib-0090){ref-type="ref"}
  32    St‐Jean‐Pelletier F   <https://www.ncbi.nlm.nih.gov/pubmed/27897402>                                                                                                                                                                                                        Article              26                              28                      41                              [91](#ehf212583-bib-0091){ref-type="ref"}
  33    Nederveen JP          <https://www.ncbi.nlm.nih.gov/pubmed/27239425>                                                                                                                                                                                                        Article              26                              32                      41                              [92](#ehf212583-bib-0092){ref-type="ref"}
  34    Girón MD              <https://www.ncbi.nlm.nih.gov/pubmed/27065075>                                                                                                                                                                                                        Article              26                              27                      34                              [93](#ehf212583-bib-0093){ref-type="ref"}
  35    de Vries NM           <https://www.ncbi.nlm.nih.gov/pubmed/27239405>                                                                                                                                                                                                        Article              26                              29                      42                              [94](#ehf212583-bib-0094){ref-type="ref"}
  36    Pinto CL              <https://www.ncbi.nlm.nih.gov/pubmed/27239423>                                                                                                                                                                                                        Article              26                              24                      44                              [95](#ehf212583-bib-0095){ref-type="ref"}
  37    Nishikawa H           <https://www.ncbi.nlm.nih.gov/pubmed/28627027>                                                                                                                                                                                                        Article              25                              26                      44                              [96](#ehf212583-bib-0096){ref-type="ref"}
  38    Lipina C              Lipid modulation of skeletal muscle mass and function                                                                                                                                                                                                 Review               25                              29                      34                              [97](#ehf212583-bib-0097){ref-type="ref"}
  39    Klassen O             <https://www.ncbi.nlm.nih.gov/pubmed/27896952>                                                                                                                                                                                                        Article              25                              26                      41                              [98](#ehf212583-bib-0098){ref-type="ref"}
  40    Sahebkar A            Curcumin: an effective adjunct in patients with statin‐associated muscle symptoms?                                                                                                                                                                    Review               25                              27                      36                              [99](#ehf212583-bib-0099){ref-type="ref"}
  41    Patel MS              Growth differentiation factor‐15 is associated with muscle mass in chronic obstructive pulmonary disease and promotes muscle wasting in vivo                                                                                                          Article              25                              28                      40                              [100](#ehf212583-bib-0100){ref-type="ref"}
  42    Lewis A               Increased expression of H19/miR‐675 is associated with a low fat‐free mass index in patients with COPD                                                                                                                                                Article              25                              30                      41                              [101](#ehf212583-bib-0101){ref-type="ref"}
  43    Go SI                 Prognostic impact of sarcopenia in patients with diffuse large B‐cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone                                                                                 Article              25                              28                      34                              [102](#ehf212583-bib-0102){ref-type="ref"}
  44    Banach M              Discussion around statin discontinuation in older adults and patients with wasting diseases                                                                                                                                                           Editorial Material   25                              28                      39                              [103](#ehf212583-bib-0103){ref-type="ref"}
  45    Tieland M             Skeletal muscle performance and ageing                                                                                                                                                                                                                Review               24                              26                      62                              [104](#ehf212583-bib-0104){ref-type="ref"}
  46    Dos Santos L          Sarcopenia and physical independence in older adults: the independent and synergic role of muscle mass and muscle function                                                                                                                            Article              24                              31                      46                              [105](#ehf212583-bib-0105){ref-type="ref"}
  47    Lerner L              MAP 3K11/GDF15 axis is a critical driver of cancer cachexia                                                                                                                                                                                           Article              24                              27                      33                              [106](#ehf212583-bib-0106){ref-type="ref"}
  48    Penna F               Effect of the specific proteasome inhibitor bortezomib on cancer‐related muscle wasting                                                                                                                                                               Article              24                              26                      37                              [107](#ehf212583-bib-0107){ref-type="ref"}
  49    Gonzalez MC           <https://www.ncbi.nlm.nih.gov/pubmed/28145079>?                                                                                                                                                                                                       Editorial Material   23                              27                      40                              [108](#ehf212583-bib-0108){ref-type="ref"}
  50    van de Bool C         <https://www.ncbi.nlm.nih.gov/pubmed/28608438>                                                                                                                                                                                                        Article              23                              26                      42                              [109](#ehf212583-bib-0109){ref-type="ref"}

###### 

Top 50 of best cited articles published between 2016 until today in Eur J Heart Fail

  Nr.   First author      Title                                                                                                                                                         Document type    Times cited in Web of Science   Times cited in Scopus   Times cited in Google Scholar                   Reference
  ----- ----------------- ------------------------------------------------------------------------------------------------------------------------------------------------------------- --------------- ------------------------------- ----------------------- ------------------------------- --------------------------------------------
  1     Ponikowski P      <https://www.ncbi.nlm.nih.gov/pubmed/27207191>                                                                                                                Article                       751                        1980                        7001                [110](#ehf212583-bib-0110){ref-type="ref"}
  2     Lyon AR           <https://www.ncbi.nlm.nih.gov/pubmed/26548803>                                                                                                                Review                        276                         291                         431                [111](#ehf212583-bib-0111){ref-type="ref"}
  3     Crespo‐Leiro MG   <https://www.ncbi.nlm.nih.gov/pubmed/27324686>                                                                                                                Article                       124                         143                         170                [112](#ehf212583-bib-0112){ref-type="ref"}
  4     Harjola VP        <https://www.ncbi.nlm.nih.gov/pubmed/26995592>                                                                                                                Article                       110                         131                         206                [113](#ehf212583-bib-0113){ref-type="ref"}
  5     van Riet EE       <https://www.ncbi.nlm.nih.gov/pubmed/26727047>                                                                                                                Review                        108                         125                         224                [114](#ehf212583-bib-0114){ref-type="ref"}
  6     Jorsal A          <https://www.ncbi.nlm.nih.gov/pubmed/27790809>                                                                                                                Article                       91                          100                         121                [115](#ehf212583-bib-0115){ref-type="ref"}
  7     Ter Maaten JM     <https://www.ncbi.nlm.nih.gov/pubmed/26861140>                                                                                                                Review                        87                          93                          111                [116](#ehf212583-bib-0116){ref-type="ref"}
  8     Jankowska EA      <https://www.ncbi.nlm.nih.gov/pubmed/26821594>                                                                                                                Review                        84                          110                         148                [117](#ehf212583-bib-0117){ref-type="ref"}
  9     Pappalardo F      <https://www.ncbi.nlm.nih.gov/pubmed/27709750>                                                                                                                Article                       83                          84                          113                [118](#ehf212583-bib-0118){ref-type="ref"}
  10    Chioncel O        <https://www.ncbi.nlm.nih.gov/pubmed/28386917>                                                                                                                Article                       83                          114                         159                [119](#ehf212583-bib-0119){ref-type="ref"}
  11    Komajda M         <https://www.ncbi.nlm.nih.gov/pubmed/28462519>                                                                                                                Article                       78                          57                          59                 [120](#ehf212583-bib-0120){ref-type="ref"}
  12    Vegter EL         <https://www.ncbi.nlm.nih.gov/pubmed/26869172>                                                                                                                Review                        78                          85                          104                [121](#ehf212583-bib-0121){ref-type="ref"}
  13    Stiermaier T      <https://www.ncbi.nlm.nih.gov/pubmed/26990821>                                                                                                                Article                       72                          78                          101                [122](#ehf212583-bib-0122){ref-type="ref"}
  14    Vidán MT          <https://www.ncbi.nlm.nih.gov/pubmed/27072307>                                                                                                                Article                       66                          77                          64                 [123](#ehf212583-bib-0123){ref-type="ref"}
  15    Triposkiadis F    <https://www.ncbi.nlm.nih.gov/pubmed/27358242>                                                                                                                Review                        64                          71                          101                [124](#ehf212583-bib-0124){ref-type="ref"}
  16    Tsuji K           <https://www.ncbi.nlm.nih.gov/pubmed/28370829>                                                                                                                Article                       63                          79                          107                [125](#ehf212583-bib-0125){ref-type="ref"}
  17    Gyöngyösi M       <https://www.ncbi.nlm.nih.gov/pubmed/28157267>                                                                                                                Review                        61                          63                          84                 [126](#ehf212583-bib-0126){ref-type="ref"}
  18    Seferović PM      <https://www.ncbi.nlm.nih.gov/pubmed/29520964>                                                                                                                Article                       60                          82                          101                [127](#ehf212583-bib-0127){ref-type="ref"}
  19    Zamorano JL       <https://www.ncbi.nlm.nih.gov/pubmed/27565769>)                                                                                                               Article                       58                          71                          92                 [128](#ehf212583-bib-0128){ref-type="ref"}
  20    Ovchinnikova ES   <https://www.ncbi.nlm.nih.gov/pubmed/26345695>                                                                                                                Article                       58                          66                          67                 [129](#ehf212583-bib-0129){ref-type="ref"}
  21    Schmidt M         <https://www.ncbi.nlm.nih.gov/pubmed/26868921>                                                                                                                Article                       57                          68                          77                 [130](#ehf212583-bib-0130){ref-type="ref"}
  22    Butler J          <https://www.ncbi.nlm.nih.gov/pubmed/28836359>                                                                                                                Review                        56                          60                          76                 [131](#ehf212583-bib-0131){ref-type="ref"}
  23    Senni M           Initiating sacubitril/valsartan (LCZ696) in heart failure: results of TITRATION, a double‐blind, randomized comparison of two uptitration regimens            Article                       54                          61                          90                 [132](#ehf212583-bib-0132){ref-type="ref"}
  24    Christ M          Heart failure epidemiology 2000‐2013: insights from the German Federal Health Monitoring System                                                               Article                       54                          59                          67                 [133](#ehf212583-bib-0133){ref-type="ref"}
  25    Vardeny O         <https://www.ncbi.nlm.nih.gov/pubmed/27283779>                                                                                                                Article                       54                          53                          67                 [134](#ehf212583-bib-0134){ref-type="ref"}
  26    Gustafsson F      <https://www.ncbi.nlm.nih.gov/pubmed/28198133>                                                                                                                Review                        53                          60                          78                 [135](#ehf212583-bib-0135){ref-type="ref"}
  27    Teerlink J        Serelaxin in addition to standard therapy in acute heart failure: rationale and design of the RELAX‐AHF‐2 study                                               Article                       53                          58                          72                 [136](#ehf212583-bib-0136){ref-type="ref"}
  28    Komajda M         <https://www.ncbi.nlm.nih.gov/pubmed/27095461>                                                                                                                Article                       53                          60                          74                 [137](#ehf212583-bib-0137){ref-type="ref"}
  29    Bauersachs J      <https://www.ncbi.nlm.nih.gov/pubmed/27338866>                                                                                                                Article                       52                          62                          85                 [138](#ehf212583-bib-0138){ref-type="ref"}
  30    Thorvaldsen T     <https://www.ncbi.nlm.nih.gov/pubmed/26869252>                                                                                                                Article                       50                          57                          64                 [139](#ehf212583-bib-0139){ref-type="ref"}
  31    Unger ED          <https://www.ncbi.nlm.nih.gov/pubmed/26635076>                                                                                                                Article                       48                          49                          66                 [140](#ehf212583-bib-0140){ref-type="ref"}
  32    Chioncel O        Clinical phenotypes and outcome of patients hospitalized for acute heart failure: the ESC Heart Failure Long‐Term Registry                                    Article                       47                          57                          72                 [141](#ehf212583-bib-0141){ref-type="ref"}
  33    Fitchett D        <https://www.ncbi.nlm.nih.gov/pubmed/27653447>                                                                                                                Review                        45                          51                          63                 [142](#ehf212583-bib-0142){ref-type="ref"}
  34    Aschauer S        <https://www.ncbi.nlm.nih.gov/pubmed/26449727>                                                                                                                Article                       45                          51                          62                 [143](#ehf212583-bib-0143){ref-type="ref"}
  35    Anker SD          Effects of ferric carboxymaltose on hospitalisations and mortality rates in iron‐deficient heart failure patients: an individual patient data meta‐analysis   Article                       44                          56                          89                 [144](#ehf212583-bib-0144){ref-type="ref"}
  36    Sliwa K           <https://www.ncbi.nlm.nih.gov/pubmed/28271625>                                                                                                                Article                       43                          49                          74                 [145](#ehf212583-bib-0145){ref-type="ref"}
  37    Maggioni AP       <https://www.ncbi.nlm.nih.gov/pubmed/26754527>                                                                                                                Article                       43                          52                          68                 [146](#ehf212583-bib-0146){ref-type="ref"}
  38    Chan MM           <https://www.ncbi.nlm.nih.gov/pubmed/26497848>                                                                                                                Article                       42                          49                          73                 [147](#ehf212583-bib-0147){ref-type="ref"}
  39    Mann DL           <https://www.ncbi.nlm.nih.gov/pubmed/26555602>                                                                                                                Article                       42                          54                          62                 [148](#ehf212583-bib-0148){ref-type="ref"}
  40    Gorter TM         <https://www.ncbi.nlm.nih.gov/pubmed/27650220>                                                                                                                Review                        42                          49                          61                 [149](#ehf212583-bib-0149){ref-type="ref"}
  41    Jansweijer JA     <https://www.ncbi.nlm.nih.gov/pubmed/27813223>                                                                                                                Article                       41                          39                          54                 [150](#ehf212583-bib-0150){ref-type="ref"}
  42    Targher G         <https://www.ncbi.nlm.nih.gov/pubmed/27790816>                                                                                                                Article                       41                          45                          43                 [151](#ehf212583-bib-0151){ref-type="ref"}
  43    Marques FZ        <https://www.ncbi.nlm.nih.gov/pubmed/27072074>                                                                                                                Article                       41                          56                          64                 [152](#ehf212583-bib-0152){ref-type="ref"}
  44    Harjola VP        <https://www.ncbi.nlm.nih.gov/pubmed/28560717>)                                                                                                               Review                        40                          44                          58                 [153](#ehf212583-bib-0153){ref-type="ref"}
  45    Ghio S            <https://www.ncbi.nlm.nih.gov/pubmed/27860029>                                                                                                                Article                       40                          46                          57                 [154](#ehf212583-bib-0154){ref-type="ref"}
  46    Demissei BG       <https://www.ncbi.nlm.nih.gov/pubmed/26634889>                                                                                                                Article                       40                          40                          46                 [155](#ehf212583-bib-0155){ref-type="ref"}
  47    Meani P           <https://www.ncbi.nlm.nih.gov/pubmed/28470925>                                                                                                                Article                       39                          45                          53                 [156](#ehf212583-bib-0156){ref-type="ref"}
  48    Pearse SG         <https://www.ncbi.nlm.nih.gov/pubmed/26869027>                                                                                                                Review                        39                          43                          54                 [157](#ehf212583-bib-0157){ref-type="ref"}
  49    Meijers WC        <https://www.ncbi.nlm.nih.gov/pubmed/27766733>                                                                                                                Article                       38                          39                          49                 [158](#ehf212583-bib-0158){ref-type="ref"}
  50    Voors AA          A systems BIOlogy Study to TAilored Treatment in Chronic Heart Failure: rationale, design, and baseline characteristics of BIOSTAT‐CHF                        Article                       38                          38                          54                 [159](#ehf212583-bib-0159){ref-type="ref"}

###### 

Top 50 of best cited articles published between 2016 until today in ESC Heart Fail

  Nr.   First author      Title                                                                                                                                                    Document type         Times cited in Web of Science   Times cited in Scopus   Times cited in Google Scholar                   Reference
  ----- ----------------- -------------------------------------------------------------------------------------------------------------------------------------------------------- -------------------- ------------------------------- ----------------------- ------------------------------- --------------------------------------------
  1     Jujo K            <https://www.ncbi.nlm.nih.gov/pubmed/27818782>                                                                                                           Article                            33                          37                          43                 [160](#ehf212583-bib-0160){ref-type="ref"}
  2     Springer J        <https://www.ncbi.nlm.nih.gov/pubmed/29154428>                                                                                                           Review                             32                          38                          46                 [161](#ehf212583-bib-0161){ref-type="ref"}
  3     Konishi M         Heart failure epidemiology and novel treatments in Japan: facts and numbers                                                                              Editorial Material                 25                          26                          36                 [162](#ehf212583-bib-0162){ref-type="ref"}
  4     Luedde M          <https://www.ncbi.nlm.nih.gov/pubmed/28772054>                                                                                                           Article                            24                          27                          34                 [163](#ehf212583-bib-0163){ref-type="ref"}
  5     Nagarajan V       <https://www.ncbi.nlm.nih.gov/pubmed/27867523>                                                                                                           Review                             21                          23                          37                 [164](#ehf212583-bib-0164){ref-type="ref"}
  6     Saitoh M          <https://www.ncbi.nlm.nih.gov/pubmed/28960880>)                                                                                                          Article                            19                          19                          19                 [165](#ehf212583-bib-0165){ref-type="ref"}
  7     Riley JP          <https://www.ncbi.nlm.nih.gov/pubmed/28451443>                                                                                                           Editorial Material                 18                          21                          27                 [166](#ehf212583-bib-0166){ref-type="ref"}
  8     Sotiropoulos K    <https://www.ncbi.nlm.nih.gov/pubmed/27818784>                                                                                                           Article                            17                          18                          23                 [167](#ehf212583-bib-0167){ref-type="ref"}
  9     Arrigo M          <https://www.ncbi.nlm.nih.gov/pubmed/27812386>                                                                                                           Article                            16                          17                          27                 [168](#ehf212583-bib-0168){ref-type="ref"}
  10    Núñez J           <https://www.ncbi.nlm.nih.gov/pubmed/27867532>                                                                                                           Article                            16                          18                          21                 [169](#ehf212583-bib-0169){ref-type="ref"}
  11    Delepaul B        <https://www.ncbi.nlm.nih.gov/pubmed/28451445>?                                                                                                          Article                            15                          17                          20                 [170](#ehf212583-bib-0170){ref-type="ref"}
  12    Hayashi T         <https://www.ncbi.nlm.nih.gov/pubmed/27818781>                                                                                                           Article                            14                          15                          24                 [171](#ehf212583-bib-0171){ref-type="ref"}
  13    Barkhudaryan A    <https://www.ncbi.nlm.nih.gov/pubmed/29154433>                                                                                                           Article                            13                          13                          17                 [172](#ehf212583-bib-0172){ref-type="ref"}
  14    Pascual‐Figal D   <https://www.ncbi.nlm.nih.gov/pubmed/29239515>                                                                                                           Article                            12                          14                          18                 [173](#ehf212583-bib-0173){ref-type="ref"}
  15    Sato A            Associations of dipeptidyl peptidase‐4 inhibitors with mortality in hospitalized heart failure patients with diabetes mellitus                           Article                            12                          12                          11                 [174](#ehf212583-bib-0174){ref-type="ref"}
  16    Martens P         <https://www.ncbi.nlm.nih.gov/pubmed/29464879>                                                                                                           Article                            11                          11                          16                 [175](#ehf212583-bib-0175){ref-type="ref"}
  17    Seropian IM       <https://www.ncbi.nlm.nih.gov/pubmed/28758719>                                                                                                           Article                            11                          12                          16                 [176](#ehf212583-bib-0176){ref-type="ref"}
  18    Lauritsen J       <https://www.ncbi.nlm.nih.gov/pubmed/29660263>                                                                                                           Review                             10                          10                          11                 [177](#ehf212583-bib-0177){ref-type="ref"}
  19    Cohen‐Solal A     Beta blocker dose and markers of sympathetic activation in heart failure patients: interrelationships and prognostic significance                        Article                            10                          13                          13                 [178](#ehf212583-bib-0178){ref-type="ref"}
  20    Jain A            The renal‐cardiac connection in subjects with preserved ejection fraction: a population based study                                                      Article                            10                           9                          12                 [179](#ehf212583-bib-0179){ref-type="ref"}
  21    Toma M            Differentiating heart failure phenotypes using sex‐specific transcriptomic and proteomic biomarker panels                                                Article                            10                          10                          12                 [180](#ehf212583-bib-0180){ref-type="ref"}
  22    Morishita T       <https://www.ncbi.nlm.nih.gov/pubmed/28772055>                                                                                                           Article                            10                          13                          17                 [181](#ehf212583-bib-0181){ref-type="ref"}
  23    Alma LJ           Shared biomarkers between female diastolic heart failure and pre‐eclampsia: a systematic review and meta‐analysis                                        Review                             10                          13                          16                 [182](#ehf212583-bib-0182){ref-type="ref"}
  24    Amina A           On admission serum sodium and uric acid levels predict 30 day rehospitalization or death in patients with acute decompensated heart failure              Article                            10                           9                          13                 [183](#ehf212583-bib-0183){ref-type="ref"}
  25    Yoshihisa A       <https://www.ncbi.nlm.nih.gov/pubmed/27867527>                                                                                                           Article                            10                          10                          11                 [184](#ehf212583-bib-0184){ref-type="ref"}
  26    Mustroph J        <https://www.ncbi.nlm.nih.gov/pubmed/30117720>                                                                                                           Article                             9                           8                           9                 [185](#ehf212583-bib-0185){ref-type="ref"}
  27    Khan MS           Renin‐angiotensin blockade in heart failure with preserved ejection fraction: a systematic review and meta‐analysis                                      Review                              9                          11                          14                 [186](#ehf212583-bib-0186){ref-type="ref"}
  28    Theidel U         <https://www.ncbi.nlm.nih.gov/pubmed/28772041>                                                                                                           Article                             9                          13                          13                 [187](#ehf212583-bib-0187){ref-type="ref"}
  29    Möckel M          <https://www.ncbi.nlm.nih.gov/pubmed/28772049>                                                                                                           Review                              9                           9                          13                 [188](#ehf212583-bib-0188){ref-type="ref"}
  30    Searle J          <https://www.ncbi.nlm.nih.gov/pubmed/27818780>                                                                                                           Editorial Material                  9                           8                          15                 [189](#ehf212583-bib-0189){ref-type="ref"}
  31    Aleksova N        <https://www.ncbi.nlm.nih.gov/pubmed/27867525>                                                                                                           Article                             9                          10                          11                 [190](#ehf212583-bib-0190){ref-type="ref"}
  32    Hoshida S         <https://www.ncbi.nlm.nih.gov/pubmed/27867528>                                                                                                           Article                             9                           9                          12                 [191](#ehf212583-bib-0191){ref-type="ref"}
  33    Porto CM          <https://www.ncbi.nlm.nih.gov/pubmed/28817241>                                                                                                           Article                             8                           7                          16                 [192](#ehf212583-bib-0192){ref-type="ref"}
  34    Pappalardo F      <https://www.ncbi.nlm.nih.gov/pubmed/29465166>                                                                                                           Article                             8                           7                          14                 [193](#ehf212583-bib-0193){ref-type="ref"}
  35    Buckley LF        <https://www.ncbi.nlm.nih.gov/pubmed/29345112>                                                                                                           Article                             8                           6                          10                 [194](#ehf212583-bib-0194){ref-type="ref"}
  36    Öhman J           <https://www.ncbi.nlm.nih.gov/pubmed/28960894>                                                                                                           Article                             8                           9                          10                 [195](#ehf212583-bib-0195){ref-type="ref"}
  37    Smedema JP        <https://www.ncbi.nlm.nih.gov/pubmed/28967698>                                                                                                           Article                             8                           9                          12                 [196](#ehf212583-bib-0196){ref-type="ref"}
  38    Jaarsma T         <https://www.ncbi.nlm.nih.gov/pubmed/28217306>                                                                                                           Editorial Material                  8                           9                          12                 [197](#ehf212583-bib-0197){ref-type="ref"}
  39    Keene D           <https://www.ncbi.nlm.nih.gov/pubmed/29984912>                                                                                                           Article                             7                           8                          11                 [198](#ehf212583-bib-0198){ref-type="ref"}
  40    Pitt B            Evaluation of an individualized dose titration regimen of patiromer to prevent hyperkalaemia in patients with heart failure and chronic kidney disease   Article                             7                          13                          12                 [199](#ehf212583-bib-0199){ref-type="ref"}
  41    Ferreira JP       <https://www.ncbi.nlm.nih.gov/pubmed/28988439>                                                                                                           Article                             7                           8                          12                 [200](#ehf212583-bib-0200){ref-type="ref"}
  42    Norberg H         <https://www.ncbi.nlm.nih.gov/pubmed/29345425>                                                                                                           Article                             7                           8                          10                 [201](#ehf212583-bib-0201){ref-type="ref"}
  43    Shirakabe A       <https://www.ncbi.nlm.nih.gov/pubmed/29388735>                                                                                                           Article                             7                           8                          10                 [202](#ehf212583-bib-0202){ref-type="ref"}
  44    Lavall D          <https://www.ncbi.nlm.nih.gov/pubmed/29676043>                                                                                                           Review                              7                           8                          14                 [203](#ehf212583-bib-0203){ref-type="ref"}
  45    Cattadori G       <https://www.ncbi.nlm.nih.gov/pubmed/29235244>                                                                                                           Review                              7                          10                          19                 [204](#ehf212583-bib-0204){ref-type="ref"}
  46    Ancion A          <https://www.ncbi.nlm.nih.gov/pubmed/28451450>                                                                                                           Article                             7                          12                          14                 [205](#ehf212583-bib-0205){ref-type="ref"}
  47    Lancellotti P     <https://www.ncbi.nlm.nih.gov/pubmed/28772051>                                                                                                           Article                             7                           9                           7                 [206](#ehf212583-bib-0206){ref-type="ref"}
  48    Peled Y           The impact of gender mismatching on early and late outcomes following heart transplantation                                                              Article                             7                           6                          10                 [207](#ehf212583-bib-0207){ref-type="ref"}
  49    Ahmed MB          <https://www.ncbi.nlm.nih.gov/pubmed/27668089>                                                                                                           Article                             7                           7                           9                 [208](#ehf212583-bib-0208){ref-type="ref"}
  50    Thomsen MM        <https://www.ncbi.nlm.nih.gov/pubmed/27867524>                                                                                                           Review                              7                           7                          13                 [209](#ehf212583-bib-0209){ref-type="ref"}

3. Results {#ehf212583-sec-0007}
==========

Each of the journals has a different impact factor ranging between 3.407 and 12.129. The change of the impact factors over the last years (2008--18) are shown *Figure* [1](#ehf212583-fig-0001){ref-type="fig"}. ESC‐HF was founded in 2014 and received its first impact factor in 2018 (3.407), whereas there are no previous impact factors to compare with. EJPC has received its first impact factor in 2011 (2.634) and, since then, steadily increased to 5.640 in 2018. EJHF has been publishing papers since 1999. Since 2008, its impact factor has steadily risen until 3 years ago when it rapidly increased from 5.135 (2015) to 12.129 (2018). JCSM received its first impact factor of 7.413 in 2013 and it increased in the following years to currently 10.754 (2018).

![Impact factor of EJHF, ESC‐HF, EJPC, and JCSM between 2008 and 2018. EJHF, European Journal of Heart Failure; EJPC, European Journal of Preventive Cardiology; ESC‐HF, ESC Heart Failure; JCSM, Journal of cachexia, sarcopenia and muscle.](EHF2-6-1291-g001){#ehf212583-fig-0001}

The precise number of citations according to WoS, Scopus, and Google Scholar are shown in *Tables* [1](#ehf212583-tbl-0001){ref-type="table"}, [2](#ehf212583-tbl-0002){ref-type="table"}, [3](#ehf212583-tbl-0003){ref-type="table"}, [4](#ehf212583-tbl-0004){ref-type="table"}. The top 50 articles in ESC‐HF were on average cited 12 (WoS), 13 (Scopus), and 17 times (Google Scholar); in JCSM 37 (WoS), 43 (Scopus), and 60 times (Google Scholar); in EJPC 41 (WoS), 56 (Scopus), and 67 times (Google Scholar); and in EJHF 76 (WoS), 108 (Scopus), and 230 times (Google Scholar). On average, the top 50 cited articles in all four journals were cited 41 (WoS), 52 (Scopus, 26% higher citations count than WoS, range 8--42% in the different journals), and 93 times (Google Scholar, 116% higher citation count than WoS, range 42--203% in the different journals, *Figure* [2](#ehf212583-fig-0002){ref-type="fig"}).

![Average number of citations from 01/2016 to 10/2019 of the top 50 cited papers in EJHF, ESC‐HF, EJPC, and JCSM. EJHF, European Journal of Heart Failure; EJPC, European Journal of Preventive Cardiology; ESC‐HF, ESC Heart Failure; JCSM, Journal of cachexia, sarcopenia and muscle.](EHF2-6-1291-g002){#ehf212583-fig-0002}

4. Discussion {#ehf212583-sec-0008}
=============

We have shown here that Scopus and Google Scholar on average have a higher citation count than WoS, whereas the difference is much larger between Google Scholar and WoS. Another systematic comparison of Google Scholar, Scopus, and WoS found that Google Scholar identified \>90% of the citations listed in Scopus and WoS. Of the additional citations that Google Scholar identified, about 50% came from non‐journal sources: conference papers, books, theses, and unpublished materials.[7](#ehf212583-bib-0007){ref-type="ref"} While WoS and Scopus predominantly used English literature for their citation count (\>90%),[8](#ehf212583-bib-0008){ref-type="ref"} Google Scholar also frequently used non‐English literature for their citation count (up to 40% of citations).[7](#ehf212583-bib-0007){ref-type="ref"} Therefore, if one wants to find all possible citations of an article, this can only be achieved by combining all three databases.[9](#ehf212583-bib-0009){ref-type="ref"} Adriaanse *et al*. have shown that WoS and Scopus did not count duplicates of papers, while Google Scholar sometimes counted one paper multiple times---additionally explaining why the citation count in Google Scholar is much higher.[10](#ehf212583-bib-0010){ref-type="ref"}

Looking at the three analysed journals publishing in the field of cardiovascular research, one can notice a volume effect regarding the ratio between Google Scholar/WoS. The citation count in ESC‐HF (average eight citations per article in WoS) is 42% higher for Google Scholar; in EJPC (average 41 citations per article in WoS), the citation count is 63% higher; and in EJHF (average 76 citations per article in WoS), the citation count is 203% higher. We think that one of the main reasons for this is that very frequently cited articles are read in many parts of the world and then are also often cited in non‐English speaking literature and non‐journal sources. Such citations can be found more often in Google Scholar.[7](#ehf212583-bib-0007){ref-type="ref"} For example, the '2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure' by Ponikowski *et al*.[110](#ehf212583-bib-0110){ref-type="ref"} have received 751 citations in WoS, but 7001 citations (+832%) in Google Scholar so far.

Regarding the 26% higher citation count in Scopus compared with WoS, we think that this might be due to the fact that Scopus has a wider database of journals than WoS (20 000 vs. 14 000 journals[11](#ehf212583-bib-0011){ref-type="ref"}), and therefore, Scopus has access to more possible citations. Still, it is important to acknowledge that Harzing *et al*.[12](#ehf212583-bib-0012){ref-type="ref"} demostrated that even though all three databases use different algorithms, each citation count shows a stable and consistent growth over time.
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